Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maier

Showing results (591-600 of 593) with videos related to

Pageof 60
Sort By:
You have reached the last page of results.This site can display upto 593 results.
The New England Journal of Medicine|November 26, 2024
Aggressive Lymphoma after CD19 CAR T-Cell TherapyGuido Kobbe, Monika Brüggemann, Ben-Niklas Baermann, et al.
Blood|January 9, 2024
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial updateMartin Dreyling, Nathan Hale Fowler, Michael Dickinson, et al.
Cell Genomics|June 20, 2022
PrecisionFDA Truth Challenge V2: Calling variants from short and long reads in difficult-to-map regionsNathan D Olson, Justin Wagner, Jennifer McDaniel, et al.
Pageof 60

Showing results (591-600 of 593) with videos related to

Sort By:
Pageof 60
You have reached the last page of results.This site can display upto 593 results.
The New England Journal of Medicine|November 26, 2024
Aggressive Lymphoma after CD19 CAR T-Cell TherapyGuido Kobbe, Monika Brüggemann, Ben-Niklas Baermann, et al.
Blood|January 9, 2024
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial updateMartin Dreyling, Nathan Hale Fowler, Michael Dickinson, et al.
Cell Genomics|June 20, 2022
PrecisionFDA Truth Challenge V2: Calling variants from short and long reads in difficult-to-map regionsNathan D Olson, Justin Wagner, Jennifer McDaniel, et al.
Pageof 60